PD-L1 serves as a double agent in separating GVL from GVHD.

about

PD-L1 serves as a double agent in separating GVL from GVHD.

Item

http://www.wikidata.org/entity/Q51054718

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

PD-L1 serves as a double agent in separating GVL from GVHD.

@en

PD-L1 serves as a double agent in separating GVL from GVHD.

@nl

type

Item

label

PD-L1 serves as a double agent in separating GVL from GVHD.

@en

PD-L1 serves as a double agent in separating GVL from GVHD.

@nl

prefLabel

PD-L1 serves as a double agent in separating GVL from GVHD.

@en

PD-L1 serves as a double agent in separating GVL from GVHD.

@nl

P1476

PD-L1 serves as a double agent in separating GVL from GVHD.

@en

P2093

Todd V Brennan

http://www.w3.org/2001/XMLSchema#string

Yiping Yang

http://www.w3.org/2001/XMLSchema#string

P2860

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

Predictive factors of activity of anti-programmed death-1/programmed death ligand-1 drugs: immunohistochemistry analysis

Immune checkpoint blockade: a common denominator approach to cancer therapy

PD-1 and its ligands in tolerance and immunity

NK cells in therapy of cancer

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

Colocalization of inflammatory response with B7-h1 expression in human melanocytic lesions supports an adaptive resistance mechanism of immune escape

B7-H1 (programmed cell death ligand 1) is required for the development of multifunctional Th1 cells and immunity to primary, but not secondary, Salmonella infection

PD-L1 has distinct functions in hematopoietic and nonhematopoietic cells in regulating T cell responses during chronic infection in mice.

Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired

P304

1627-1630

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI94196

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28414300

http://www.w3.org/2001/XMLSchema#string

P932

5409065

http://www.w3.org/2001/XMLSchema#string